scholarly article | Q13442814 |
review article | Q7318358 |
P356 | DOI | 10.1016/S0925-4439(03)00058-9 |
P698 | PubMed publication ID | 12757929 |
P2093 | author name string | James W Goding | |
Bert Grobben | |||
Herman Slegers | |||
P2860 | cites work | Differential mechanisms of inorganic pyrophosphate production by plasma cell membrane glycoprotein-1 and B10 in chondrocytes | Q22010626 |
Potential signalling roles for UTP and UDP: sources, regulation and release of uracil nucleotides | Q41633188 | ||
Ecto-nucleotide pyrophosphatase modulates the purinoceptor-mediated signal transduction and is inhibited by purinoceptor antagonists | Q41790500 | ||
Purification and properties of nucleotide pyrophosphatase from human placenta | Q42067772 | ||
Reversal of increased lymphocyte PC-1 activity in patients with type 2 diabetes treated with metformin. | Q42482330 | ||
Decreased insulin receptor tyrosine kinase activity and plasma cell membrane glycoprotein-1 overexpression in skeletal muscle from obese women with gestational diabetes mellitus (GDM): evidence for increased serine/threonine phosphorylation in pregn | Q42489803 | ||
Agonists of the P2Y(AC)-receptor activate MAP kinase by a ras-independent pathway in rat C6 glioma | Q42510805 | ||
Elevated plasma cell membrane glycoprotein levels and diminished insulin receptor autophosphorylation in obese, insulin-resistant rhesus monkeys | Q42519172 | ||
Assignment of Pdnp2, the gene encoding phosphodiesterase I/nucleotide pyrophosphatase 2, to mouse chromosome 15D2. | Q42620525 | ||
Phosphorylation and nucleotide-dependent dephosphorylation of hepatic polypeptides related to the plasma cell differentiation antigen PC-1. | Q42810437 | ||
No correlation of plasma cell 1 overexpression with insulin resistance in diabetic rats and 3T3-L1 adipocytes | Q42813816 | ||
A function for phosphoinositide 3-kinase beta lipid products in coupling beta gamma to Ras activation in response to lysophosphatidic acid. | Q42817181 | ||
Regulation of purified hepatic PC-1 (phosphodiesterase-I/nucleotide pyrophosphatase) by threonine auto(de)phosphorylation and by binding of acidic fibroblast growth factor | Q42824256 | ||
Evidence that P2Y4 nucleotide receptors are involved in the regulation of rat aortic smooth muscle cells by UTP and ATP. | Q43183864 | ||
Up-regulated expression of the phosphodiesterase nucleotide pyrophosphatase family member PC-1 is a marker and pathogenic factor for knee meniscal cartilage matrix calcification | Q43607181 | ||
Enzymatic activation of autotaxin by divalent cations without EF-hand loop region involvement | Q43628431 | ||
A cluster of three single nucleotide polymorphisms in the 3'-untranslated region of human glycoprotein PC-1 gene stabilizes PC-1 mRNA and is associated with increased PC-1 protein content and insulin resistance-related abnormalities | Q43687884 | ||
Diabetic microvascular complications are not associated with two polymorphisms in the GLUT-1 and PC-1 genes regulating glucose metabolism in Caucasian type 1 diabetic patients | Q43690511 | ||
Multiple ecto-nucleotidases in PC12 cells: identification and cellular distribution after heterologous expression | Q43735199 | ||
Small molecule insulin receptor activators potentiate insulin action in insulin-resistant cells | Q43748942 | ||
Impaired insulin-receptor autophosphorylation is an early defect in fat-fed, insulin-resistant rats | Q43771427 | ||
Polymorphism in ecto-nucleotide pyrophosphatase/phosphodiesterase 1 gene (ENPP1/PC-1) and early development of advanced diabetic nephropathy in type 1 diabetes | Q43935493 | ||
Mechanisms of apoptosis induced by purine nucleosides in astrocytes. | Q43968136 | ||
Skeletal muscle content of membrane glycoprotein PC-1 in obesity. Relationship to muscle glucose transport. | Q46042563 | ||
Overexpression of membrane glycoprotein PC-1 can influence insulin action at a post-receptor site | Q46114318 | ||
Inhibition of insulin receptor phosphorylation by PC-1 is not mediated by the hydrolysis of adenosine triphosphate or the generation of adenosine | Q46157707 | ||
The development of insulin resistance with high fat feeding in rats does not involve either decreased insulin receptor tyrosine kinase activity or membrane glycoprotein PC-1. | Q46413723 | ||
Expression of the nucleoside triphosphate pyrophosphohydrolase PC-1 is induced by basic fibroblast growth factor (bFGF) and modulated by activation of the protein kinase A and C pathways in osteoblast-like osteosarcoma cells | Q46831739 | ||
Elevated PC-1 content in cultured skin fibroblasts correlates with decreased in vivo and in vitro insulin action in nondiabetic subjects: evidence that PC-1 may be an intrinsic factor in impaired insulin receptor signaling | Q47904035 | ||
Treatment of fibroblast-like synoviocytes with IFN-gamma results in the down-regulation of autotaxin mRNA. | Q48056751 | ||
Modulation of astroglial cell proliferation by analogues of adenosine and ATP in primary cultures of rat striatum | Q48160127 | ||
Role of the mouse ank gene in control of tissue calcification and arthritis | Q22254612 | ||
PC-1 nucleoside triphosphate pyrophosphohydrolase deficiency in idiopathic infantile arterial calcification | Q24290745 | ||
The Q allele variant (GLN121) of membrane glycoprotein PC-1 interacts with the insulin receptor and inhibits insulin signaling more effectively than the common K allele variant (LYS121) | Q24291091 | ||
Membrane glycoprotein PC-1 and insulin resistance in non-insulin-dependent diabetes mellitus | Q24310636 | ||
Disruption of IRS-2 causes type 2 diabetes in mice | Q24316112 | ||
Cloning, chromosomal localization, and tissue expression of autotaxin from human teratocarcinoma cells | Q24319171 | ||
Molecular cloning and chromosomal assignment of the human brain-type phosphodiesterase I/nucleotide pyrophosphatase gene (PDNP2) | Q24319985 | ||
Molecular cloning and chromosomal localization of PD-Ibeta (PDNP3), a new member of the human phosphodiesterase I genes | Q24321341 | ||
Mutations in ANKH cause chondrocalcinosis | Q24616817 | ||
Expression of the murine plasma cell nucleotide pyrophosphohydrolase PC-1 is shared by human liver, bone, and cartilage cells. Regulation of PC-1 expression in osteosarcoma cells by transforming growth factor-beta | Q24628679 | ||
Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production | Q24673806 | ||
Molecular cloning of cDNAs for human fibroblast nucleotide pyrophosphatase | Q28115252 | ||
Membrane glycoprotein PC-1 inhibition of insulin receptor function occurs via direct interaction with the receptor alpha-subunit | Q28141526 | ||
Association of the human NPPS gene with ossification of the posterior longitudinal ligament of the spine (OPLL) | Q28142507 | ||
A polymorphism (K121Q) of the human glycoprotein PC-1 gene coding region is strongly associated with insulin resistance | Q28144111 | ||
Genomic structure and promoter analysis of the ecto-phosphodiesterase I gene (PDNP3) expressed in glial cells | Q28145952 | ||
The basophil activation marker defined by antibody 97A6 is identical to the ectonucleotide pyrophosphatase/phosphodiesterase 3 | Q28187816 | ||
Inorganic pyrophosphate generation and disposition in pathophysiology | Q28201357 | ||
New perspectives into the molecular pathogenesis and treatment of type 2 diabetes | Q28203726 | ||
PC-1 amino acid variant (K121Q) has no impact on progression of diabetic nephropathy in type 1 diabetic patients | Q28216380 | ||
Identification of human plasma lysophospholipase D, a lysophosphatidic acid-producing enzyme, as autotaxin, a multifunctional phosphodiesterase | Q28217851 | ||
Identification of the disulfide bonds in the recombinant somatomedin B domain of human vitronectin | Q28218295 | ||
Autotaxin is an N-linked glycoprotein but the sugar moieties are not needed for its stimulation of cellular motility | Q28284827 | ||
Stimulation of tumor cell motility linked to phosphodiesterase catalytic site of autotaxin | Q28289403 | ||
Autophosphorylation of PC-1 (alkaline phosphodiesterase I/nucleotide pyrophosphatase) and analysis of the active site | Q28300765 | ||
Autotaxin is an exoenzyme possessing 5'-nucleotide phosphodiesterase/ATP pyrophosphatase and ATPase activities | Q28301252 | ||
IL-1 beta- and IL-4-induced down-regulation of autotaxin mRNA and PC-1 in fibroblast-like synoviocytes of patients with rheumatoid arthritis (RA) | Q28347268 | ||
P2Y(AC)(-)-receptor agonists enhance the proliferation of rat C6 glioma cells through activation of the p42/44 mitogen-activated protein kinase | Q28359340 | ||
A major locus for fasting insulin concentrations and insulin resistance on chromosome 6q with strong pleiotropic effects on obesity-related phenotypes in nondiabetic Mexican Americans | Q28361785 | ||
Mutation in Npps in a mouse model of ossification of the posterior longitudinal ligament of the spine | Q28505453 | ||
Effect of in situ retroviral interleukin-4 transfer on established intracranial tumors | Q48267756 | ||
Phosphodiesterase I, a novel adhesion molecule and/or cytokine involved in oligodendrocyte function. | Q48579837 | ||
The paracrine role of tumour-derived mIL-4 on tumour-associated endothelium. | Q48638541 | ||
The K121Q variant of the human PC-1 gene is not associated with insulin resistance or type 2 diabetes among Danish Caucasians. | Q50567631 | ||
Association between the human glycoprotein PC-1 gene and elevated glucose and insulin levels in a paired-sibling analysis. | Q51553988 | ||
Increased adipose tissue PC-1 protein content, but not tumour necrosis factor-alpha gene expression, is associated with a reduction of both whole body insulin sensitivity and insulin receptor tyrosine-kinase activity. | Q51576506 | ||
Identification of B10, an alkaline phosphodiesterase of the apical plasma membrane of hepatocytes and biliary cells, in rat serum: increased levels following bile duct ligation and during the development of cholangiocarcinoma. | Q53437411 | ||
An ecto-nucleotide pyrophosphatase is one of the main enzymes involved in the extracellular metabolism of ATP in rat C6 glioma. | Q55477149 | ||
Mutant insulin receptors in syndromes of insulin resistance | Q61908582 | ||
Plasma cell membrane glycoprotein gene Pca-1 (alkaline phosphodiesterase I) is linked to the proto-oncogene Myb on mouse chromosome 10 | Q67517963 | ||
Effect of colchicine and phalloidin on the distribution of three plasma membrane antigens in rat hepatocytes: comparison with bile duct ligation | Q68203992 | ||
Transforming growth factor beta 1 stimulates inorganic pyrophosphate elaboration by porcine cartilage | Q68242453 | ||
Immunoaffinity purification and characterization of nucleotide pyrophosphatase from human placenta | Q69808751 | ||
Synovial fluid inorganic pyrophosphate concentration and nucleotide pyrophosphohydrolase activity in basic calcium phosphate deposition arthropathy and Milwaukee shoulder syndrome | Q69824060 | ||
Correlation of plasma interleukin 1 levels with disease activity in rheumatoid arthritis | Q69923865 | ||
The inhibition of the insulin receptor by the receptor protein PC-1 is not specific and results from the hydrolysis of ATP | Q71150200 | ||
Assignment of the gene for gp 130RB13-6 (Pdnpno) to rat chromosome band 1p12 by in situ hybridization | Q71234007 | ||
Elevated plasma levels of transforming growth factor-beta 1 in NIDDM | Q71715886 | ||
PC-1 content in skeletal muscle of non-obese, non-diabetic subjects: relationship to insulin receptor tyrosine kinase and whole body insulin sensitivity | Q71736384 | ||
Threonine autophosphorylation and nucleotidylation of the hepatic membrane protein PC-1 | Q71776721 | ||
Adenosine effects upon insulin action on lipolysis and glucose transport in human adipocytes | Q71926800 | ||
Evidence for a role of Rho-like GTPases and stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK) in transforming growth factor beta-mediated signaling | Q71984903 | ||
Causal link between nucleotide pyrophosphohydrolase overactivity and increased intracellular inorganic pyrophosphate generation demonstrated by transfection of cultured fibroblasts and osteoblasts with plasma cell membrane glycoprotein-1. Relevance | Q71993438 | ||
Elevation of alkaline phosphatase activity induced by parathyroid hormone in osteoblast-like cells from the spinal hyperostotic mouse TWY (twy/twy) | Q72207190 | ||
Biosynthesis and intracellular transport of a bile canalicular plasma membrane protein: studies in vivo and in the perfused rat liver | Q72271852 | ||
Modulation of ecto-nucleoside triphosphate pyrophosphatase activity of human osteoblast-like bone cells by 1 alpha,25-dihydroxyvitamin D3, 24R,25-dihydroxyvitamin D3, parathyroid hormone, and dexamethasone | Q72846799 | ||
Inhibition of phosphodiesterase/pyrophosphatase activity of PC-1 by its association with glycosaminoglycans | Q73036334 | ||
Expression of the putative inhibitor of the insulin receptor tyrosine kinase PC-1 in dermal fibroblasts from patients with syndromes of severe insulin resistance | Q73709697 | ||
A PC-1 amino acid variant (K121Q) is associated with faster progression of renal disease in patients with type 1 diabetes and albuminuria | Q73929166 | ||
Cyclocreatine inhibits stimulated motility in tumor cells possessing creatine kinase | Q77180614 | ||
Growth inhibition of HL-60 cells by extracellular ATP: concentration-dependent involvement of a P2 receptor and adenosine generation | Q77350654 | ||
A third fibronectin type III domain in the extracellular region of the insulin receptor family | Q77779611 | ||
Increased expression of pro-inflammatory cytokines and metalloproteinase-1 by TGF-beta1 in synovial fibroblasts from rheumatoid arthritis and normal individuals | Q77982972 | ||
Adenosine and cerebral ischemia: therapeutic future or death of a brave concept? | Q78166840 | ||
Pyrophosphohydrolase activity and inorganic pyrophosphate content of cultured human skin fibroblasts. Elevated levels in some patients with calcium pyrophosphate dihydrate deposition disease | Q34578925 | ||
Animal models of pathologic calcification | Q34618202 | ||
A mechanism of repression of TGFbeta/ Smad signaling by oncogenic Ras | Q35193411 | ||
Lilly Lecture: molecular mechanisms of insulin resistance. Lessons from patients with mutations in the insulin-receptor gene | Q35233886 | ||
Signaling by extracellular ATP: physiological and pathological considerations in neuronal-astrocytic interactions | Q35238710 | ||
Surface alloantigens of plasma cells | Q36270407 | ||
Inhibition of angiogenesis by interleukin 4. | Q36401812 | ||
Affinity purification and cDNA cloning of rat neural differentiation and tumor cell surface antigen gp130RB13-6 reveals relationship to human and murine PC-1. | Q36701829 | ||
In vitro differentiation of neural progenitor cells from prenatal rat brain: common cell surface glycoprotein on three glial cell subsets | Q36857604 | ||
Insulin resistance--mechanisms, syndromes, and implications | Q37278330 | ||
ATP--a fast neurotransmitter. | Q40487593 | ||
Purinergic receptors on insulin-secreting cells | Q40666423 | ||
A central role for the JNK pathway in mediating the antagonistic activity of pro-inflammatory cytokines against transforming growth factor-beta-driven SMAD3/4-specific gene expression. | Q40690939 | ||
Autotaxin promotes motility via G protein-coupled phosphoinositide 3-kinase gamma in human melanoma cells | Q40739267 | ||
Apoptosis induced by extracellular ATP in the mouse neuroblastoma cell line N1E-115: studies on involvement of P2 receptors and adenosine | Q40740508 | ||
Adenosine-induced apoptosis in glomerular mesangial cells | Q40741926 | ||
Inducible expression of a constitutively active mutant of mitogen-activated protein kinase kinase 7 specifically activates c-JUN NH2-terminal protein kinase, alters expression of at least nine genes, and inhibits cell proliferation | Q40767784 | ||
Retinoic acid-induced expression of autotaxin in N-myc-amplified neuroblastoma cells | Q40807002 | ||
Cellular insulin action and insulin resistance | Q40812896 | ||
Constitutive release of ATP and evidence for major contribution of ecto-nucleotide pyrophosphatase and nucleoside diphosphokinase to extracellular nucleotide concentrations | Q40866051 | ||
Autotaxin (ATX), a potent tumor motogen, augments invasive and metastatic potential of ras-transformed cells | Q40904277 | ||
Autotaxin expression in non-small-cell lung cancer | Q40939277 | ||
Matrix vesicle plasma cell membrane glycoprotein-1 regulates mineralization by murine osteoblastic MC3T3 cells. | Q40951338 | ||
Inhibition of transforming growth factor-beta/SMAD signalling by the interferon-gamma/STAT pathway. | Q40968846 | ||
Purines and their roles in apoptosis | Q41080130 | ||
Modulation of nucleotide pyrophosphatase in plasmacytoma cells | Q41155376 | ||
Biochemistry, localization and functional roles of ecto-nucleotidases in the nervous system | Q41205766 | ||
Ectonucleotidases, purine nucleoside transporter, and function of the bile canalicular plasma membrane of the hepatocyte. | Q41353443 | ||
Ecto-nucleoside triphosphate pyrophosphohydrolase activity and calcium pyrophosphate dihydrate crystal deposition disease | Q41366822 | ||
Understanding inorganic pyrophosphate metabolism: toward prevention of calcium pyrophosphate dihydrate crystal deposition | Q41471077 | ||
Comparison of phosphohydrolase activities from articular cartilage in Calcium Pyrophosphate deposition disease and primary osteoarthritis | Q41531668 | ||
Developmental expression analysis of murine autotaxin (ATX) | Q28511840 | ||
Biochemical and molecular identification of distinct forms of alkaline phosphodiesterase I expressed on the apical and basolateral plasma membrane surfaces of rat hepatocytes | Q28570773 | ||
EGF receptor transactivation is obligatory for protein synthesis stimulation by G protein-coupled receptors | Q28573695 | ||
Identification of a phosphodiesterase I/nucleotide pyrophosphatase-related gene mRNA in rat vascular smooth muscle cells by the differential display approach | Q28576171 | ||
Identification and characterization of a soluble form of the plasma cell membrane glycoprotein PC-1 (5'-nucleotide phosphodiesterase) | Q28589328 | ||
Structural and catalytic similarities between nucleotide pyrophosphatases/phosphodiesterases and alkaline phosphatases | Q28590714 | ||
Structural basis of allotypes of ecto-nucleotide pyrophosphatase/phosphodiesterase (plasma cell membrane glycoprotein PC-1) in the mouse and rat, and analysis of allele-specific xenogeneic antibodies | Q28592839 | ||
Banting lecture 1988. Role of insulin resistance in human disease | Q29547283 | ||
Rho GTPases control polarity, protrusion, and adhesion during cell movement | Q29614244 | ||
An integrated physical map of 8q22-q24: use in positional cloning and deletion analysis of Langer-Giedion syndrome. | Q30650410 | ||
Beta,gamma-methylene ATP-induced cAMP formation in C6Bu-1 cells: involvement of local metabolism and subsequent stimulation of adenosine A2B receptor | Q31832292 | ||
Neuroprotective role of adenosine in cerebral ischaemia | Q33188275 | ||
Synovial fluid pyrophosphate and nucleoside triphosphate pyrophosphatase: comparison between normal and diseased and between inflamed and non-inflamed joints | Q33563495 | ||
Ecto-protein kinases: ecto-domain phosphorylation as a novel target for pharmacological manipulation? | Q33763432 | ||
Modulation of purinergic neurotransmission. | Q33768366 | ||
Release of ATP and UTP from astrocytoma cells | Q33768392 | ||
Interleukin 1 beta suppresses transforming growth factor-induced inorganic pyrophosphate (PPi) production and expression of the PPi-generating enzyme PC-1 in human chondrocytes | Q33838365 | ||
Differential regulation of the expression of nucleotide pyrophosphatases/phosphodiesterases in rat liver | Q33860934 | ||
Pharmacology of cloned P2X receptors | Q33932194 | ||
Nucleotide pyrophosphatases/phosphodiesterases on the move | Q33934668 | ||
Characterization of a di-leucine-based signal in the cytoplasmic tail of the nucleotide-pyrophosphatase NPP1 that mediates basolateral targeting but not endocytosis | Q33948220 | ||
Adenosine in the central nervous system: release mechanisms and extracellular concentrations | Q33955930 | ||
Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization | Q34035649 | ||
Extracellular metabolism of ATP and other nucleotides | Q34101805 | ||
Molecular pharmacology of P2Y-receptors | Q34101812 | ||
Synergistic induction of tumor antigens by Wnt-1 signaling and retinoic acid revealed by gene expression profiling | Q34113095 | ||
Differential effect of adenosine on tumor and normal cell growth: focus on the A3 adenosine receptor | Q34124450 | ||
Comparison of alterations in insulin signalling pathway in adipocytes from Type II diabetic pregnant women and women with gestational diabetes mellitus | Q34130391 | ||
Phosphatidylinositol 3-kinases in tumor progression | Q34135631 | ||
Up-regulated expression of cartilage intermediate-layer protein and ANK in articular hyaline cartilage from patients with calcium pyrophosphate dihydrate crystal deposition disease | Q34165065 | ||
Recent advances in our understanding of insulin action and insulin resistance | Q34209698 | ||
ATP-induced chondrocalcinosis | Q34289601 | ||
Purinergic signalling: ATP release | Q34431931 | ||
Purinergic signaling and vascular cell proliferation and death | Q34555187 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | pathophysiology | Q1135939 |
P304 | page(s) | 1-19 | |
P577 | publication date | 2003-05-01 | |
P1433 | published in | Biochimica et Biophysica Acta | Q864239 |
P1476 | title | Physiological and pathophysiological functions of the ecto-nucleotide pyrophosphatase/phosphodiesterase family | |
P478 | volume | 1638 |
Q39989919 | 8-BuS-ATP derivatives as specific NTPDase1 inhibitors. |
Q41983445 | A CD38/CD203a/CD73 ectoenzymatic pathway independent of CD39 drives a novel adenosinergic loop in human T lymphocytes |
Q46358207 | A highly sensitive CE-UV method with dynamic coating of silica-fused capillaries for monitoring of nucleotide pyrophosphatase/phosphodiesterase reactions |
Q33324404 | A mouse model of pulmonary metastasis from spontaneous osteosarcoma monitored in vivo by Luciferase imaging |
Q37994174 | A2 adenosine receptors and vascular pathologies |
Q60043872 | ADSCs and adipocytes are the main producers in the autotaxin-lysophosphatidic acid axis of breast cancer and healthy mammary tissue in vitro |
Q54527062 | ATP acts as a survival signal and prevents the mineralization of aortic valve. |
Q47153776 | ATP-degrading ENPP1 is required for survival (or persistence) of long-lived plasma cells |
Q39887352 | Activity and expression of ecto-nucleotide pyrophosphate/phosphodiesterases in a hepatic stellate cell line |
Q37545375 | Activity-dependent release of adenosine: a critical re-evaluation of mechanism. |
Q37864112 | Adenosine and blood platelets |
Q38658907 | Adenosine and immune imbalance in visceral leishmaniasis: the possible role of ectonucleotidases |
Q46282086 | Adenosine derived from ecto-nucleotidases in calcific aortic valve disease promotes mineralization through A2a adenosine receptor |
Q87431579 | Alterations in the extracellular catabolism of nucleotides and platelet aggregation induced by high-fat diet in rats: effects of α-tocopherol |
Q28537750 | Antiplatelet activity, P2Y₁ and P2Y₁₂ inhibition, and metabolism in plasma of stereoisomers of diadenosine 5',5'″-P¹ ,P⁴-dithio-P²,P³-chloromethylenetetraphosphate |
Q40575040 | Assessing basophil activation by using flow cytometry and mass cytometry in blood stored 24 hours before analysis. |
Q33645954 | Autosomal-recessive hypophosphatemic rickets is associated with an inactivation mutation in the ENPP1 gene |
Q36930924 | Autotaxin (ATX): a multi-functional and multi-modular protein possessing enzymatic lysoPLD activity and matricellular properties |
Q42642222 | Autotaxin is Related to Metabolic Dysfunction and Predicts Alzheimer's Disease Outcomes |
Q36399256 | Autotaxin, a lysophospholipase D with pleomorphic effects in oncogenesis and cancer progression |
Q41490870 | Autotaxin, a secreted lysophospholipase D, is essential for blood vessel formation during development |
Q34020834 | Basal release of ATP: an autocrine-paracrine mechanism for cell regulation |
Q37138426 | Basophil activation test by flow cytometry: present and future applications in allergology. |
Q24298713 | Biochemical and molecular characterization of a novel choline-specific glycerophosphodiester phosphodiesterase belonging to the nucleotide pyrophosphatase/phosphodiesterase family |
Q81041417 | Biochemical characterization of ecto-nucleotide pyrophosphatase/phosphodiesterase (E-NPP, E.C. 3.1.4.1) from rat heart left ventricle |
Q30615893 | Cardiac myocyte-secreted cAMP exerts paracrine action via adenosine receptor activation. |
Q52597448 | Cell Phenotype Transitions in Cardiovascular Calcification. |
Q36274918 | Cell-surface enzymes in control of leukocyte trafficking |
Q34031794 | Cellular function and molecular structure of ecto-nucleotidases. |
Q34456325 | Characterization of ectonucleotidases in human medulloblastoma cell lines: ecto-5'NT/CD73 in metastasis as potential prognostic factor |
Q35057746 | Characterization of monoclonal antibodies to the plasma cell alloantigen ENPP1. |
Q50888390 | Characterization of the structure, dynamics and allosteric pathways of human NPP1 in its free form and substrate-bound complex from molecular modeling. |
Q84584191 | Cloning, expression, and characterization of Schistosoma japonicum tegument protein phosphodiesterase-5 |
Q28115795 | Cloning, purification, and identification of the liver canalicular ecto-ATPase as NTPDase8 |
Q37217072 | Cole Disease Results from Mutations in ENPP1. |
Q34104045 | Computational identification and experimental characterization of substrate binding determinants of nucleotide pyrophosphatase/phosphodiesterase 7. |
Q35518063 | Counter-regulatory phosphatases TNAP and NPP1 temporally regulate tooth root cementogenesis |
Q27673871 | Crystal structure of Enpp1, an extracellular glycoprotein involved in bone mineralization and insulin signaling |
Q34359969 | Dexamethasone enhances ATP-induced inflammatory responses in endothelial cells |
Q39860148 | Differential ectonucleotidase expression in human bladder cancer cell lines |
Q33377267 | Differential response of human basophil activation markers: a multi-parameter flow cytometry approach |
Q55113686 | Direct molecular dissection of tumor parenchyma from tumor stroma in tumor xenograft using mass spectrometry-based glycoproteomics. |
Q46324884 | Distribution of ectonucleotidases in the rodent brain revisited |
Q36287519 | E-NPP3 controls plasmacytoid dendritic cell numbers in the small intestine |
Q47440925 | ENPP1 and ESR1 genotypes associated with subclassifications of craniofacial asymmetry and severity of temporomandibular disorders |
Q38831813 | ENPP1 and ESR1 genotypes influence temporomandibular disorders development and surgical treatment response in dentofacial deformities. |
Q58102990 | ENPP1-Fc prevents neointima formation in generalized arterial calcification of infancy through the generation of AMP |
Q50294729 | ENPPs hydrolyse CoA-SH to PPANT, PAP |
Q42008606 | Ecto-5'-nucleotidase: Structure function relationships |
Q41834732 | Ecto-nucleoside triphosphate diphosphohydrolase 1 (E-NTPDase1/CD39) regulates neutrophil chemotaxis by hydrolyzing released ATP to adenosine |
Q46899899 | Ecto-nucleotide pyrophosphatase/phosphodiesterase as part of a multiple system for nucleotide hydrolysis by platelets from rats: kinetic characterization and biochemical properties. |
Q50224587 | Ectonucleotidase inhibitors: a patent review (2011-2016). |
Q36350059 | Ectonucleotidases in solid organ and allogeneic hematopoietic cell transplantation |
Q27002950 | Ectonucleotidases in tumor cells and tumor-associated immune cells: an overview |
Q28115649 | Effects of Different Variants in the ENPP1 Gene on the Functional Properties of Ectonucleotide Pyrophosphatase/Phosphodiesterase Family Member 1 |
Q46113390 | Endotoxemia alters nucleotide hydrolysis in platelets of rats. |
Q93551725 | Enzymes |
Q43119328 | Enzymes that hydrolyze adenine nucleotides in platelets and polymorphisms in the alpha2 gene of integrin alpha2beta1 in patients with von Willebrand disease |
Q40695891 | Establishing Porcine Monocyte-Derived Macrophage and Dendritic Cell Systems for Studying the Interaction with PRRSV-1. |
Q28571713 | Expression and regulation of Enpp2 in rat uterus during the estrous cycle |
Q36471271 | Expression of plasma cell alloantigen 1 defines layered development of B-1a B-cell subsets with distinct innate-like functions |
Q36570543 | Flow-assisted allergy diagnosis: current applications and future perspectives. |
Q35667354 | Gene Expression Profiling in Peripheral Blood Cells and Synovial Membranes of Patients with Psoriatic Arthritis |
Q41986289 | Generalized arterial calcification of infancy and pseudoxanthoma elasticum: two sides of the same coin |
Q92565633 | Generation and Function of Non-cell-bound CD73 in Inflammation |
Q28072659 | Genetics Underlying an Individualized Approach to Adult Spinal Disorders |
Q38700649 | IL15RA is required for osteoblast function and bone mineralization |
Q28252822 | Identification of CD13, CD107a, and CD164 as novel basophil-activation markers and dissection of two response patterns in time kinetics of IgE-dependent upregulation |
Q37201221 | Identification of ectonucleotide pyrophosphatase/phosphodiesterase 3 (ENPP3) as a regulator of N-acetylglucosaminyltransferase GnT-IX (GnT-Vb). |
Q92665200 | Inborn errors of mitochondrial acyl-coenzyme a metabolism: acyl-CoA biology meets the clinic |
Q38050028 | Inflammation, pain, and pressure--purinergic signaling in oral tissues |
Q28239967 | Inhibition of autotaxin by lysophosphatidic acid and sphingosine 1-phosphate |
Q30409061 | Integrated electroosmotic perfusion of tissue with online microfluidic analysis to track the metabolism of cystamine, pantethine, and coenzyme A. |
Q42150686 | Integration of P2Y receptor-activated signal transduction pathways in G protein-dependent signalling networks |
Q24629255 | International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy |
Q38297778 | Is autotaxin (ENPP2) the link between hepatitis C and hepatocellular cancer? |
Q41351296 | K+ depolarization evokes ATP, adenosine and glutamate release from glia in rat hippocampus: a microelectrode biosensor study |
Q57708072 | Large-volume sample stacking with polarity switching for monitoring of nucleotide pyrophosphatase/phosphodiesterase 1 (NPP1) reactions by capillary electrophoresis |
Q33645895 | Loss-of-function ENPP1 mutations cause both generalized arterial calcification of infancy and autosomal-recessive hypophosphatemic rickets |
Q92027606 | Lysophosphatidic Acid and Autotaxin-associated Effects on the Initiation and Progression of Colorectal Cancer |
Q37957734 | Measurement of purine release with microelectrode biosensors |
Q28277019 | Mechanisms of disease: Ectonucleotide pyrophosphatase phosphodiesterase 1 as a 'gatekeeper' of insulin receptors |
Q35692398 | Mechanisms of induction of adenosine receptor genes and its functional significance |
Q41676786 | Mechanistic and Evolutionary Insights from Comparative Enzymology of Phosphomonoesterases and Phosphodiesterases across the Alkaline Phosphatase Superfamily |
Q44839348 | Mediation of spontaneous knee osteoarthritis by progressive chondrocyte ATP depletion in Hartley guinea pigs |
Q35743894 | Metabolic consequences of ENPP1 overexpression in adipose tissue. |
Q35839006 | Metabolic pathways and physiological and pathological significances of lysolipid phosphate mediators |
Q36183732 | Metabolism of circulating ADP in the bloodstream is mediated via integrated actions of soluble adenylate kinase-1 and NTPDase1/CD39 activities |
Q37135548 | Modulation of purinergic signaling by NPP-type ectophosphodiesterases |
Q46822898 | Murine and human autotaxin alpha, beta, and gamma isoforms: gene organization, tissue distribution, and biochemical characterization |
Q37275168 | NTPDase and 5'-nucleotidase activities in physiological and disease conditions: new perspectives for human health |
Q36226844 | Non-HKD phospholipase D enzymes: new players in phosphatidic acid signaling? |
Q35913646 | Normocalcemia is maintained in mice under conditions of calcium malabsorption by vitamin D-induced inhibition of bone mineralization. |
Q36460476 | Nucleotide signaling in nervous system development |
Q36488614 | Ossification of the posterior longitudinal ligament: an update on its biology, epidemiology, and natural history |
Q27930848 | Pho5p and newly identified nucleotide pyrophosphatases/ phosphodiesterases regulate extracellular nucleotide phosphate metabolism in Saccharomyces cerevisiae |
Q93498514 | Phosphatidylcholine-specific phospholipase D (E.C. 3.1.4.4) |
Q36305556 | Phosphodiesterase-Ialpha/autotaxin (PD-Ialpha/ATX): a multifunctional protein involved in central nervous system development and disease |
Q34769231 | Physiologic and pathologic functions of the NPP nucleotide pyrophosphatase/phosphodiesterase family focusing on NPP1 in calcification |
Q24678496 | Potential involvement of adipocyte insulin resistance in obesity-associated up-regulation of adipocyte lysophospholipase D/autotaxin expression |
Q41846275 | Promiscuous sulfatase activity and thio-effects in a phosphodiesterase of the alkaline phosphatase superfamily |
Q35563944 | Proteomics of the human endometrial glandular epithelium and stroma from the proliferative and secretory phases of the menstrual cycle |
Q89604984 | Purinergic Signaling in Glioma Progression |
Q38207600 | Purinergic receptors and nucleotide processing ectoenzymes: Their roles in regulating mesenchymal stem cell functions |
Q35978155 | Quinazoline-4-piperidine sulfamides are specific inhibitors of human NPP1 and prevent pathological mineralization of valve interstitial cells |
Q38821434 | Regulation of allergic inflammation by the ectoenzyme E-NPP3 (CD203c) on basophils and mast cells |
Q36958262 | Renal calcium stones: insights from the control of bone mineralization |
Q50342142 | Role of ectonucleotidases in the synapse formation during brain development: physiological and pathological implications. |
Q35983181 | Sclerostin is a locally acting regulator of late-osteoblast/preosteocyte differentiation and regulates mineralization through a MEPE-ASARM-dependent mechanism |
Q96109756 | Skeletal abnormalities secondary to antenatal etidronate treatment for suspected generalised arterial calcification of infancy |
Q35540914 | Some aspects of purinergic signaling in the ventricular system of porcine brain |
Q39807695 | Specific requirements for Vgamma9Vdelta2 T cell stimulation by a natural adenylated phosphoantigen. |
Q44838130 | Subcellular targeting and function of osteoblast nucleotide pyrophosphatase phosphodiesterase 1. |
Q59939745 | Submucosal connective tissue-type mast cells contribute to the production of lysophosphatidic acid (LPA) in the gastrointestinal tract through the secretion of autotaxin (ATX)/lysophospholipase D (lysoPLD) |
Q41903446 | Substrate-specifying determinants of the nucleotide pyrophosphatases/phosphodiesterases NPP1 and NPP2. |
Q37682494 | Systems Genetics Approach Identifies Gene Pathways and Adamts2 as Drivers of Isoproterenol-Induced Cardiac Hypertrophy and Cardiomyopathy in Mice |
Q38063159 | The CD39-adenosinergic axis in the pathogenesis of renal ischemia-reperfusion injury |
Q30486745 | The Concise Guide to PHARMACOLOGY 2013/14: enzymes. |
Q37527792 | The autotaxin-LPA axis emerges as a novel regulator of lymphocyte homing and inflammation |
Q43000529 | The effect of divalent cations on the catalytic activity of the human plasma 3'-exonuclease |
Q33806334 | The genetic basis of ankylosing spondylitis: new insights into disease pathogenesis |
Q51245857 | The hepatic ectonucleotide pyrophosphatase/phosphodiesterase 1 gene mRNA abundance is reduced by insulin and induced by dexamethasone. |
Q36463221 | The role of membrane glycoprotein plasma cell antigen 1/ectonucleotide pyrophosphatase phosphodiesterase 1 in the pathogenesis of insulin resistance and related abnormalities |
Q28643191 | The venomous cocktail of the vampire snail Colubraria reticulata (Mollusca, Gastropoda) |
Q38151635 | Therapeutic potentials of ecto-nucleoside triphosphate diphosphohydrolase, ecto-nucleotide pyrophosphatase/phosphodiesterase, ecto-5'-nucleotidase, and alkaline phosphatase inhibitors |
Q34483168 | Transcriptional analysis of a unique set of genes involved in Schistosoma mansoni female reproductive biology |
Q38232436 | Unraveling the contribution of ectoenzymes to myeloma life and survival in the bone marrow niche. |
Q37836561 | γδ T cell receptor ligands and modes of antigen recognition |
Search more.